Welcome to our dedicated page for Somnigroup International SEC filings (Ticker: SGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Somnigroup International Inc. may sell mattresses, but its SEC paperwork is anything but soft. Investors scour filings to see how Tempur-Pedic, Sealy and Stearns & Foster each drive revenue, how foam price swings hit margins, and which executives are loading up on shares. Our platform brings every document together, from the Somnigroup annual report 10-K simplified to Somnigroup Form 4 insider transactions real-time, so you never miss a disclosure.
Need the Somnigroup quarterly earnings report 10-Q filing to compare direct-to-consumer sales with wholesale? Curious about Somnigroup 8-K material events explained after a factory expansion? Stock Titan’s AI-powered summaries translate dense accounting notes into plain language, spotlight segment growth, and flag new risk factors. You’ll also get instant alerts on Somnigroup insider trading Form 4 transactions and a concise Somnigroup proxy statement executive compensation breakdown—no 300-page PDFs required.
Whether you’re tracking Somnigroup executive stock transactions Form 4 ahead of earnings, completing a Somnigroup earnings report filing analysis, or simply understanding Somnigroup SEC documents with AI, you’ll find every form—10-K, 10-Q, 8-K, S-4, DEF 14A—updated in real time from EDGAR. Spend less time searching and more time deciding if this sleep giant belongs in your portfolio.
Somnigroup International Inc. (ticker: SGI) filed its Q2-25 10-Q. Net sales jumped 52% YoY to $1.88 bn, driven by the 5 Feb 2025 $5.1 bn acquisition of Mattress Firm, which added $949 m revenue in the quarter. Gross profit rose 60% to $827 m, lifting gross margin 210 bp to 44.0%. However, higher selling, marketing (+92%) and G&A (+63%) tied to the enlarged retail footprint limited operating income growth to 4% ($180 m). Net income slipped 7% to $99 m and diluted EPS fell 22% to $0.47 as share count expanded 19%.
Balance sheet impacts: total assets doubled to $11.4 bn; goodwill rose $3.5 bn. Debt climbed to $4.95 bn (vs $3.84 bn) after drawing on the 2023 Credit Agreement; net leverage rises, though the company remains covenant-compliant. Equity increased to $2.84 bn from $0.56 bn on stock issuance. Cash ended at $98 m (-$19 m YoY) after funding the deal.
Cash flow: 1H-25 operating cash flow held at $293 m; acquisition spending drove a $2.88 bn investing outflow offset by $2.68 bn new borrowings.
Management recorded a $13.9 m loss on divesting 176 stores (Sleep Outfitters & 73 Mattress Firm sites) on 1 May 2025 to satisfy regulators. Pro-forma data show 2024 revenue would have been $1.99 bn with Mattress Firm, but EPS dilution and one-off stock-comp charges would have produced a net loss.
Guidance not provided; risk factors emphasize integration execution, leverage, and macro pressure on U.S. consumers.
On 7 Aug 2025, Somnigroup International Inc. (NYSE: SGI) filed a Form 8-K under Item 7.01 – Regulation FD Disclosure. The sole purpose of the filing is to furnish an updated Investor Presentation, attached as Exhibit 99.1. Management indicates the deck may be used in future investor meetings. Consistent with Reg FD, the material is explicitly furnished, not filed; therefore it carries no Exchange Act liability and will not be incorporated into registration statements unless specifically referenced. No earnings figures, balance-sheet data, strategic transactions or guidance updates accompany the exhibit. Apart from the routine signature block and exhibit list, the 8-K contains no additional quantitative or qualitative disclosures, making it a standard investor-relations communication with neutral impact on the investment thesis.
On 7 Aug 2025, Somnigroup International Inc. filed a Form 8-K outlining two reportable events.
- Item 2.02 – Results of Operations: The company issued a press release (Exhibit 99.1) announcing financial results for Q2 FY25 ended 30 Jun 2025. Numerical metrics are not included in the 8-K; investors must review the attached exhibit for revenue, EPS and guidance details.
- Item 8.01 – Other Events: The Board declared a quarterly $0.15 cash dividend per share, payable 5 Sep 2025 to shareholders of record on 21 Aug 2025 (Exhibit 99.2).
No other material transactions, executive changes or financing activities were disclosed. The furnished information is expressly not deemed “filed” under Section 18 of the Exchange Act.
FAQ
What is the current stock price of Somnigroup International (SGI)?
What is the market cap of Somnigroup International (SGI)?
